the aid library

LIST OPTIONS

Filter

6807

Capacité juridique et droit à la décision – Formation de base de QualiyRights de l‘OMS-Services sociaux et de santé mentale

World Health Organisation (WHO) (2022) C_WHO

Les modules de formation et d’orientation QualityRights ont été élaborés pour renforcer les connaissances, les compétences et la compréhension des principales parties prenantes sur la manière de promouvoir les droits des personnes en situation de handicap psychosocial, intellectuel ou cogni... more

Download (1180)

View PDF (1375)

Best practice guidelines for mental health promotion programs: Refugees

Centre for Addiction and Mental Health (CAMH); Dalla Lana School of Public Health, University of Toronto; Toronto Public Health (2012) C1

This resource is the third in a series of online guides for promoting positive mental health across the lifespan. This resource provides health and social service providers (“practitioners”) with current evidence-based approaches in the application of mental health promotion concepts and princip... more

Download (473)

View PDF (698)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (396)

View PDF (299)

Plaidoyer pour la santé mentale, le handicap et les droits humains : guide d’orientation QualityRights de l’OMS

Organisation Mondiale de la Santé OMS (2019) C_WHO

Download (390)

View PDF (585)

Female Genital Mutilation/Cutting: A statistical overview and exploration of the dynamics of change

United Nations Children's Fund (UNICEF) (2015) CC

This report is a comprehensive statistical overview of female genital mutilation/cutting (FGM/C) in the 29 countries where the practice is concentrated. Analysis of the data reflects current perspectives on FGM/C, informed by the latest policy, programmatic and theoretical evidence.

Download (266)

View PDF (419)

Plans individualisés de rétablissement et outil d’auto-support : outil d’auto-support QualityRights de l’OMS

Organisation Mondiale de la Santé OMS (2021) C_WHO

Download (841)

View PDF (1777)

Ethical considerations for use of unregistered interventions for Ebola viral disease

World Health Organization (2014)

West Africa is experiencing the largest, most severe, most complex outbreak of Ebola virus disease in history. On 11 August 2014, WHO convened a consultation where the participants concluded that in the particular context of the current Ebola outbreak in West Africa, it is ethically acceptable to of... more

Download (327)

View PDF (480)

War child: "I´ve moved, my rights haven't" (Towards a global action plan for children forced to flee)
recommended

War Child War Child (2016) C1

We live in a world in which 28 million children have been driven from their homes as a result of conflict, persecution and insecurity¹. If current trends continue, more than 63 million children could be forced to flee by 2025², of which over 25 million will cross borders and become refugees. At... more

Download (448)

View PDF (327)

Alter(n) und Migration: Was wissen wir über die Lebenssituation älterer Menschen mit Migrationsgeschichte in Deutschland?

Susanne Bartig DeZIM Institut (2022) CC

Viele der derzeit in Deutschland lebenden Älteren mit Migrationsgeschichte sind im Zielland ihrer Migration unter spezifischen Bedingungen, die mit dem Migrations- und Integrationsprozess einhergehen können, älter geworden. Allerdings ist bislang wenig über diese Gruppe bekannt. Wie wirkt sich d... more

External Link

Business models for sustainable development: Projects of global extension of medical technologies of Japan

Nozaki, I.; Y. Sugiura; N. Fujita et al. Global Health & Medicine (2021) C1

Japan has been implementing projects of global extension of medical technologies under an official development assistance policy to improve public health and medicine by promoting Japanese medical technologies worldwide. The current work examines the impact and goals of implementing this new scheme.... more

Download (255)

View PDF (428)

Guidelines for the use of non-pharmaceutical measures to delay and mitigate the impact of 2019-nCoV

European Centre for Disease Prevention and Control ECDC (2020) C1

This document provides guidance on the application of non-pharmaceutical countermeasures to minimise the spread of the 2019 novel coronavirus (2019-nCoV) in the population. Some of the measures proposed refer specifically to certain phases of the epidemic (containment or mitigation phases), and can ... more

Download (218)

View PDF (281)

Repurposing Established Radio and Audio Series to Address the COVID-19 Educational Crises

Richmond, S Education Development Center (EDC) (2020) C2

Reusing a legacy interactive audio instruction (IAI) program to provide education in a humanitarian crisis is a quick solution and a smart use of previous investments (“Learning in the Time of Ebola”). This article highlights and advises on the issues that relate to adapting and updating previou... more

Download (311)

View PDF (327)

Rétablissement et droit à la santé : formation de base QualityRights de l’OMS : services sociaux et de santé mentale : guide de formation

Organisation Mondiale de la Santé OMS (2022) C_WHO

Download (219)

View PDF (243)

Hesitation and Refusal Factors in Individuals' Decision-Making Processes Regarding a Coronavirus Disease 2019 Vaccination

Cerda A. A., Garcia L. Y. (2021) C2

Introduction: Considering the global prevalence of coronavirus disease 2019 (COVID-19), a vaccine is being developed to control the disease as a complementary solution to hygiene measures—and better, in social terms, than social distancing. Given that a vaccine will eventually be produced, informa... more

Download (931)

View PDF (1696)

Impact of WASH Interventions during Disease Outbreaks in Humanitarian Emergencies: A systematic review protocol
recommended

Tufts University, Oxfam (2016) CC

In this review, the editors will investigate the impact of eight WASH interventions in preventing (reducing the risk of) and controlling outbreaks in LMIC, with particular focus on three diseases of current concern to the response community – cholera, Ebola, and Hepatitis E. Additionally, we will ... more

Download (252)

View PDF (546)

Policy brief: mainstreaming quality of care in empanelled hospitals under AB PM-JAY

World Health Organisation (WHO) (2022) C_WHO

This report presents key findings from a study carried out on the ‘Mainstreaming quality of care in empanelled hospitals under PMJAY’. It provides a detailed analysis of current coverage and perceptions of quality accreditation and certification across PMJAY empanelled hospitals from three diffe... more

Download (331)

View PDF (429)

Soutien individuel par et pour les personnes ayant un savoir expérientiel en santé mentale : guide d’orientation QualityRights de l’OMS

Organisation Mondiale de la Santé OMS (2022) C_WHO

Download (393)

View PDF (418)

Alcohol and Public Health in the Americas

Pan American Health Organization (PAHO) (2007) C_WHO

Making the Case for Alcohol as a Public Health Threat in the Region. The purpose of this document is to explain the need for making alcohol a top public health priority in the region and the need for national and regional action. Current evidence-based research shows that alcohol consumption and dri... more

External Link

Strengthening mental health responses to COVID-19 in the Americas: A health policy analysis and recommendations

A. Tausch; Oliveira e Souza, R.; Martinez Viciana, C.; et al. Pan American Health Organization (2021) CC

The COVID-19 pandemic is having a major impact on the mental health of populations in the Americas. Studies show high rates of depression and anxiety, among other psychological symptoms, particularly among women, young people, those with pre-existing mental health conditions, health workers, and p... more

External Link

Melarsoprol Resistance in African Trypanosomiasis

Fairlamb, A.H.; Horn, D. Elsevier Ltd. (2018) CC

Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT). Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s. Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher... more

War child: "I´ve moved, my rights haven't" (Towards a global action plan for children forced to flee) recommended

Impact of WASH Interventions during Disease Outbreaks in Humanitarian Emergencies: A systematic review protocol recommended

War child: "I´ve moved, my rights haven't" (Towards a global action plan for children forced to flee)
recommended

Impact of WASH Interventions during Disease Outbreaks in Humanitarian Emergencies: A systematic review protocol
recommended